|
Business Segment (Tables)
|
6 Months Ended |
|
Jun. 29, 2012
|
| Geographic Areas, Long-Lived Assets [Abstract] |
|
| Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] |
| | Long-lived tangible assets by geographic area are as follows (in thousands): | | | | As of | | | | | June 29, | | | December 30, | | | | | 2012 | | | 2011 | | | United States | $ | 123,362 | | $ | 113,693 | | | Rest of world | | 33,018 | | | 32,113 | | | Total | $ | 156,380 | | $ | 145,806 |
|
| Geographic Areas, Revenues from External Customers [Abstract] |
|
| Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block] |
| | | | | Three Months Ended | | Six Months Ended | | | | | | | June 29, | | | July 1, | | | June 29, | | | July 1, | | | | | 2012 | | | 2011 | | | 2012 | | | 2011 | | | Sales by geographic area: | | | | United States | $ | 84,378 | | $ | 61,092 | | $ | 166,784 | | $ | 126,293 | | | Non-Domestic locations: | | | | | | | | | | | | | | | Puerto Rico | | 26,681 | | | 24,651 | | | 50,221 | | | 50,832 | | | | Belgium | | 15,053 | | | 17,628 | | | 30,391 | | | 36,597 | | | | United Kingdom & Ireland | | 12,331 | | | 17,626 | | | 24,688 | | | 28,119 | | | | Rest of world | | 28,105 | | | 25,527 | | | 53,567 | | | 53,517 | | | | | Total sales | $ | 166,548 | | $ | 146,524 | | $ | 325,651 | | $ | 295,358 |
|
| Reconciliation from Segment Totals to Consolidated [Abstract] |
|
| Reconciliation of Revenue from Segments to Consolidated [Table Text Block] |
| | | | | Three Months Ended | | Six Months Ended | | | | | | | June 29, | | | July 1, | | | June 29, | | | July 1, | | | Sales: | | 2012 | | | 2011 | | | 2012 | | | 2011 | | | Implantable Medical | | | | | | | | | | | | | | | CRM/Neuromodulation | $ | 80,025 | | $ | 77,724 | | $ | 155,160 | | $ | 155,761 | | | | Vascular Access | | 12,481 | | | 10,769 | | | 24,117 | | | 21,243 | | | | Orthopaedic | | 32,860 | | | 37,922 | | | 63,906 | | | 77,511 | | | | | Total Implantable Medical | | 125,366 | | | 126,415 | | | 243,183 | | | 254,515 | | | Electrochem | | | | | | | | | | | | | | | Portable Medical | | 20,407 | | | 2,012 | | | 39,127 | | | 4,151 | | | | Energy/Environmental | | 16,879 | | | 16,016 | | | 35,249 | | | 31,858 | | | | Other | | 3,896 | | | 2,081 | | | 8,092 | | | 4,834 | | | | | Total Electrochem | | 41,182 | | | 20,109 | | | 82,468 | | | 40,843 | | | | | Total sales | $ | 166,548 | | $ | 146,524 | | $ | 325,651 | | $ | 295,358 |
|
| Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] |
| | | | | Three Months Ended | | Six Months Ended | | | | | | | June 29, | | | July 1, | | | June 29, | | | July 1, | | | | | 2012 | | | 2011 | | | 2012 | | | 2011 | | | Segment income from operations: | | | | | | | | | | | | | | | Implantable Medical | $ | 11,396 | | $ | 17,700 | | $ | 21,508 | | $ | 36,647 | | | | Electrochem | | 6,199 | | | 4,852 | | | 10,670 | | | 9,259 | | | Total segment income from operations | | 17,595 | | | 22,552 | | | 32,178 | | | 45,906 | | | Unallocated operating expenses | | (6,504) | | | (4,249) | | | (9,889) | | | (9,637) | | | Operating income as reported | | 11,091 | | | 18,303 | | | 22,289 | | | 36,269 | | | Unallocated other expense | | (4,221) | | | (5,539) | | | (9,300) | | | (5,678) | | | Income before provision for income taxes | $ | 6,870 | | $ | 12,764 | | $ | 12,989 | | $ | 30,591 |
|
| Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] |
| | Four customers accounted for a significant portion of the Company’s sales as follows: | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | | | | | June 29, | | | July 1, | | | June 29, | | | July 1, | | | | | 2012 | | | 2011 | | | 2012 | | | 2011 | | | Customer A | | 18% | | | 19% | | | 19% | | | 20% | | | Customer B | | 15% | | | 17% | | | 14% | | | 17% | | | Customer C | | 10% | | | 14% | | | 10% | | | 14% | | | Customer D | | 6% | | | 8% | | | 7% | | | 8% | | | | | | | 49% | | | 58% | | | 50% | | | 59% |
|